Claire Verschraegen, MD
Claire Verschraegen, MD, has been appointed Director of the Division of Medical Oncology and Associate Director of the Translational Research Program at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James). Her appointment was effective June 1, 2017.
Dr. Verschraegen also holds the Diane Nye and Michael Rayden Chair in Innovative Cancer Research and serves as Professor of Internal Medicine at The Ohio State University College of Medicine.
In her new role, Dr. Verschraegen oversees a division of more than 50 faculty members who provide subspecialized care and/or conduct research for breast, endocrine, gastrointestinal, genitourinary, gynecologic, head and neck, prostate, and skin cancers, as well as soft-tissue sarcoma and spine tumors.
Earlier Roles
Prior to joining The OSUCCC–James, Dr. Verschraegen served as Professor of Internal Medicine and Hematology/Oncology Division Director at the University of Vermont Cancer Center. In this role, she held numerous leadership roles, including Director of the Cancer Service Line at Fletcher Allen Health Care and Co-Director of the University of Vermont Cancer Center.
Throughout her professional career, Dr. Verschraegen has been active in the European Organisation for Research and Treatment of Cancer and in national cooperative oncology groups including SWOG (formerly, the Southwest Oncology Group), the Gynecologic Oncology Group, and the Alliance for Clinical Trials in Oncology, where she served as the institutional principal investigator of cooperative group trials at the University of Vermont. She will serve in the same capacity for The Ohio State University Comprehensive Cancer Center. She also serves on the Alliance Board of Directors.
Dr. Verschraegen earned her medical degree at the Université Libre de Bruxelles in Belgium and trained at the Institut Jules Bordet in internal medicine. She then completed a cancer research fellowship at the Stehlin Foundation for Cancer Research and internal medicine residency training at the University of Houston, followed by a medical oncology fellowship at The University of Texas MD Anderson Cancer Center. ■
